Tag Archives: MRSA
Rockefeller University Hospital shares $2.8 million contract to study preventing drug-resistant infections in the community
The Community Acquired MRSA Project (“CAMP2″) will enroll patients with skin infections, provide English- and Spanish-language health education materials about community-acquired drug-resistant staph infections, and incorporate a home visit program by community health workers to evaluate the effectiveness of household decontamination in preventing reinfection and transmission. More »
Scientists at Rockefeller University and Astex Pharmaceuticals have discovered a new broad range antibiotic that kills a wide range of bacteria, including drug-resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs, in mice. The antibiotic, Epimerox, targets weaknesses in bacteria that have long been exploited by viruses that attack them, known as phage.
The ever escalating war between evolving bacteria and antibiotics could be taking a promising turn in favor of the humans. Scientists have genetically engineered a powerful killer of one of the most dangerous bacteria, methicillin-resistant Staphylococcus aureus (MRSA). It’s been tested on MRSA in the test tube, on infections in mice and a clinical trial has begun to probe its ability to kill MRSA infected cells from psoriasis lesions in people. Next up, per the recommendation of the FDA, is a test in minipigs. “It’s the start of a new class of drugs,” says the lead researcher, and early signs suggest it’s stronger than anything of its kind currently on the market. More »
At a time when bacteria continue to acquire “superbug” powers, researchers at Rockefeller University are devising ways to strip them of their infectious properties. Now they’ve figured out how to drill holes through the tough hide of gram-positive bacteria without obliterating them, and in so doing, have made it possible to study, from the inside out, most of the known bacteria on the planet. More »
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But Rockefeller University scientists have tested a new drug, called Ceftobiprole, that may be able to outwit them. More »
A team of researchers led by scientists from The Rockefeller University and the Public Health Research Institute (PHRI) used molecular fingerprinting techniques to track the spread of methicillin-resistant Staphylococcus aureus (MRSA) in 12 hospitals in the New York City metropolitan area. The findings, published in the July issue of the Journal of Infectious Diseases, confirms the prevalence of antibiotic-resistant strains of staph in New York City. More »